2024
Antipsychotic drugs in first-episode psychosis: a target trial emulation in the FEP-CAUSAL Collaboration
Szmulewicz A, Martínez-Alés G, Logan R, Ferrara M, Kelly C, Fredrikson D, Gago J, Conderino S, Díaz-Caneja C, Galvañ J, Thorpe L, Srihari V, Yatham L, Sarpal D, Shinn A, Arango C, Öngür D, Hernán M, Collaboration O. Antipsychotic drugs in first-episode psychosis: a target trial emulation in the FEP-CAUSAL Collaboration. American Journal Of Epidemiology 2024, 193: 1081-1087. PMID: 38576166, DOI: 10.1093/aje/kwae029.Peer-Reviewed Original ResearchFirst-episode psychosisFirst-generation agentsAntipsychotic therapyAntipsychotic drugsPsychosis onsetPsychotic disordersEpisode psychosisAripiprazolePaliperidoneRisk of hospitalizationPsychosisTarget trialsRisperidoneOlanzapineFirst-line therapyTreatment discontinuationEUFESTObservational cohortAntipsychoticsQuetiapineRandomized trialsPrimary outcomeAbsolute riskRisk differenceClinical questions
2008
Atypical antipsychotics for people with both schizophrenia and depression
Furtado V, Srihari V, Kumar A. Atypical antipsychotics for people with both schizophrenia and depression. 2008, 2012: cd005377. PMID: 18254078, PMCID: PMC4171386, DOI: 10.1002/14651858.cd005377.pub2.Peer-Reviewed Original ResearchConceptsAtypical antipsychotic drugsAntipsychotic drugsGroup RegisterRelative riskCochrane Schizophrenia Group's RegisterNew atypical antipsychotic drugHomogenous dichotomous dataRelevant pharmaceutical companiesCo-morbid depressionConfidence intervalsTreatment of peopleLower depression scoresHaloperidol comparisonsTreat basisRandomised trialsAtypical antipsychoticsDATA COLLECTIONClinical trialsHamilton scorePANSS scoresDepression scoresDichotomous dataMean differenceMore trialsSchizophrenia